Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/IIa single-arm study of AL8326 in small cell lung cancer
CTR20201805Phase 2Active
- Sponsor
- Adcentrx Therapeutics
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AL8326 in small cell lung cancer (SCLC), sponsored by Adcentrx Therapeutics. Started Oct 2020; status: active.
02
Drugs
AL8326
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on CTR20201805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201805.